BERLIN and ERFURT, Germany, and ÅRSLEV, Denmark – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028), offering German sufferers with a variety of pharmaceutical grade medical hashish merchandise and Schroll Medical ApS (“Schroll”), a Danish cultivator of medical hashish, announce that they’ve entered into a non-exclusive, three-year provide settlement for bulk and packaged EU-GMP hashish flower which shall be branded below the AMP medical hashish model when supplied within the German market.

Schroll is a partnership between Schroll Flowers, one among Europe’s largest producers of hydrangeas and Aphria Inc., (TSX:APHA) a number one Canadian hashish producer, to pursue the cultivation and worldwide distribution of EU-GMP licensed medical hashish. Schroll was one of many first medical hashish cultivators to obtain a licence for cultivation and processing from the Danish authorities in 2018. Schroll’s large-scale greenhouse cultivation facility positioned in Årslev, Denmark, was EU-GMP licensed by the Danish Medicines Agency in November 2019 and started manufacturing this yr. The facility employs over 35 folks and may produce 6,000 kilograms of dried medical hashish flowers yearly. AMP accomplished the on-site audit of Schroll’s manufacturing plant final week.

AMP will register merchandise bought from Schroll with The Federal Institute for Drugs and Medical Devices (BfArM) and has utilized for an irradiation license (“AMRadV License”) for Schroll merchandise, which AMP plans to promote within the German market.

Dr. Stefan Feuerstein, Director and President of AMP, commented, “This is our first large scale European supply agreement that will ensure we have a steady supply of high quality medical cannabis for the German market. AMP will initially import one high THC medical cannabis flower strain from Denmark which will be branded under the AMP Classic brand beginning in January 2021”.

Mr. Carsten Schroll, CEO of Schrollcommented, “Success in Germany, the largest medical cannabis market in Europe and the world, is the pathway to success in Europe as we expand our production to supply European markets. AMP’s strong distribution network and medical cannabis sales team will ensure we will be a significant supplier to Germany.”

About Schroll Medical ApS
Schroll Medical ApS is the one producer of medical hashish that’s each Danish-led and Danish-owned and licensed to domesticate and promote medical hashish.  Through its mum or dad firm Schroll Management ApS, Schroll Medical ApS has entry to intensive expertise with plant breeding and the institution of environment friendly plant manufacturing. The objective is that pharmaceutical manufacturing can benefit from this data to develop the best varieties and merchandise in collaboration with docs and universities in Denmark and the EU. For extra info, please go to:

About AMP German Cannabis Group
AMP German Cannabis Group is licensed to import European Union – Good Manufacturing Practice (EU-GMP) medical hashish from Europe and elsewhere into Germany. AMP sources, shops, transports, delivers, and sells medical hashish merchandise to pharmaceutical distributors or pharmacists straight, the one point-of-sale for medical hashish to German sufferers with a doctor’s prescription.

AMP has entered into a non-exclusive distribution settlement for medical hashish with a number one distributor of prescribed drugs merchandise to greater than 13,000 pharmacies all through Germany. AMP imports medical hashish from Europe and abroad.

AMP has sponsored a six-episode roundtable dialogue sequence about medical hashish in Germany. The Roundtable Series can be found as a podcast or as a video. In Episode #1 titled “Medical Cannabis in Germany” Dr. Franjo Grotenhermen, a German medical physician and medical hashish skilled and Dr. Stefan Feuerstein, President of AMP, be a part of the moderator Mr. Holger Scholze in an in-depth dialogue about medical hashish in Germany. AMP Roundtable Series: For extra info, please go to:

Source link